SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193805-24-000439
Filing Date
2024-03-22
Accepted
2024-03-22 17:44:07
Documents
2
Group Members
DEERFIELD HEALTHCARE INNOVATIONS FUND II, L.P.DEERFIELD MANAGEMENT COMPANY, L.P.DEERFIELD MGMT HIF II, L.P.DEERFIELD MGMT V, L.P.DEERFIELD PRIVATE DESIGN FUND V, L.P.

Document Format Files

Seq Description Document Type Size
1 e619413_sc13d-biomx.htm SC 13D 172369
2 e619413_ex99-1.htm EX-99.1 9509
  Complete submission text file 0001193805-24-000439.txt   183570
Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address
Flynn James E (Filed by) CIK: 0001352546 (see all company filings)

Type: SC 13D

Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Subject) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90744 | Film No.: 24776423
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)